| For: | Tsujimoto T, Kawaratani H, Kitazawa T, Yoshiji H, Fujimoto M, Uemura M, Fukui H. Immunotherapy for nonalcoholic steatohepatitis using the multiple cytokine production modulator Y-40138. World J Gastroenterol 2009; 15(44): 5533-5540 [PMID: 19938191 DOI: 10.3748/wjg.15.5533] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i44/5533.htm |
| Number | Citing Articles |
| 1 |
Kirstine S. Tølbøl, Birgit Stierstorfer, Jörg F. Rippmann, Sanne S. Veidal, Kristoffer T. G. Rigbolt, Tanja Schönberger, Matthew P. Gillum, Henrik H. Hansen, Niels Vrang, Jacob Jelsing, Michael Feigh, Andre Broermann. Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis. Digestive Diseases and Sciences 2019; 64(5) doi: 10.1007/s10620-018-5395-7
|
| 2 |
Tatsuhiro Tsujimoto, Hideto Kawaratani, Toshiyuki Kitazawa, Masahito Uemura, Hiroshi Fukui. Innate Immune Reactivity of the Ileum–Liver Axis in Nonalcoholic Steatohepatitis. Digestive Diseases and Sciences 2012; 57(5) doi: 10.1007/s10620-012-2073-z
|
| 3 |
Yaron Ilan. Immune Therapy for Nonalcoholic Steatohepatitis. Journal of Clinical Gastroenterology 2013; 47(4) doi: 10.1097/MCG.0b013e31827873dc
|
| 4 |
Jing Liu, Zhen‐jie Zhuang, Dong‐xue Bian, Xiao‐jie Ma, Yun‐hao Xun, Wen‐jun Yang, Yan Luo, Yin‐lan Liu, Ling Jia, Yan Wang, Ming‐li Zhu, De‐wei Ye, Gang Zhou, Guo‐qiang Lou, Jun‐ping Shi. Toll‐like receptor‐4 signalling in the progression of non‐alcoholic fatty liver disease induced by high‐fat and high‐fructose diet in mice. Clinical and Experimental Pharmacology and Physiology 2014; 41(7) doi: 10.1111/1440-1681.12241
|
| 5 |
Ankica Vujovic, Andjelka M. Isakovic, Sonja Misirlic-Dencic, Jovan Juloski, Milan Mirkovic, Andja Cirkovic, Marina Djelic, Ivana Milošević. IL-23/IL-17 Axis in Chronic Hepatitis C and Non-Alcoholic Steatohepatitis—New Insight into Immunohepatotoxicity of Different Chronic Liver Diseases. International Journal of Molecular Sciences 2023; 24(15) doi: 10.3390/ijms241512483
|
| 6 |
M I Koukourakis. Radiation damage and radioprotectants: new concepts in the era of molecular medicine. The British Journal of Radiology 2012; 85(1012) doi: 10.1259/bjr/16386034
|
| 7 |
Y. TORINIWA, M. MURAMATSU, Y. ISHII, E. RIYA, K. MIYAJIMA, S. OHSHIDA, K. KITATANI, S. TAKEKOSHI, T. MATSUI, S. KUME, T. YAMADA, T. OHTA. Pathophysiological Characteristics of Non-Alcoholic Steatohepatitis-Like Changes in Cholesterol-Loaded Type 2 Diabetic Rats. Physiological Research 2018; doi: 10.33549/physiolres.933784
|
| 8 |
Masahiko Matsumoto, Natsuko Hada, Yoshiyuki Sakamaki, Akiko Uno, Toshihiko Shiga, Chiaki Tanaka, Tsuneo Ito, Asao Katsume, Masayuki Sudoh. An improved mouse model that rapidly develops fibrosis in non‐alcoholic steatohepatitis. International Journal of Experimental Pathology 2013; 94(2) doi: 10.1111/iep.12008
|
| 9 |
Ankica Vujović, Ivana Milošević, Marina Đelić. The influence of the immune response on liver fibrosis progression in chronic liver diseases. Medicinski podmladak 2025; 76(2) doi: 10.5937/mp76-48987
|
| 10 |
Hideto Kawaratani, Tatsuhiro Tsujimoto, Toshiyuki Kitazawa, Hitoshi Yoshiji, Masahito Uemura, Hiroshi Fukui. Therapeutic effects of cytokine modulator Y‐40138 in the rat alcoholic liver disease model. Journal of Gastroenterology and Hepatology 2011; 26(4) doi: 10.1111/j.1440-1746.2011.06658.x
|